S 1240 Massachusetts Senate · 193rd Legislature (2023-2024)

An Act to educate on prescription opioids

This bill requires doctors in Massachusetts to educate patients about the risks of prescription opioids when specific high-risk conditions are present. It directly affects healthcare practitioners and patients who are prescribed Schedule II opioids under certain circumstances, such as high daily dosages, concurrent benzodiazepine use, or a history of substance use disorder. Under the new rules, doctors must inform patients about the need for naloxone, an overdose reversal agent, and document in the medical record why this education was skipped if it is not provided. The legislation aims to improve safety by ensuring that at-risk individuals are aware of potential dangers and available life-saving resources before receiving opioid prescriptions.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action Apr 18, 2024
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
5
Key actions
2
Committee
2
Mar 7, 2024
Upper · Passed
Bill reported favorably by committee and referred to the committee on Health Care Financing
upper
Feb 16, 2023
Lower · Passed
House concurred
lower
Feb 16, 2023
Committee
Referred to the committee on Mental Health, Substance Use and Recovery
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Brendan Crighton
Brendan Crighton
DDemocratic
MA
Third Essex